Skip to main content
Top
Published in: Nutrition Journal 1/2012

Open Access 01-12-2012 | Research

Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study

Authors: Jui-Hua Huang, Yi-Fa Lu, Fu-Chou Cheng, John Ning-Yuean Lee, Leih-Ching Tsai

Published in: Nutrition Journal | Issue 1/2012

Login to get access

Abstract

Background

Type 2 diabetes mellitus is a major global public health problem in the worldwide and is increasing in aging populations. Magnesium intake may be one of the most important factors for diabetes prevention and management. Low magnesium intake may exacerbate metabolic abnormalities. In this study, the relationships of magnesium intake with metabolic parameters, depression and physical activity in elderly patients with type 2 diabetes were investigated.

Methods

This cross-sectional study involved 210 type 2 diabetes patients aged 65 years and above. Participants were interviewed to obtain information on lifestyle and 24-hour dietary recall. Assessment of depression was based on DSM-IV criteria. Clinical variables measured included anthropometric measurements, blood pressure, and biochemical determinations of blood and urine samples. Linear regression was applied to determine the relationships of magnesium intake with nutritional variables and metabolic parameters.

Results

Among all patients, 88.6% had magnesium intake which was less than the dietary reference intake, and 37.1% had hypomagnesaemia. Metabolic syndromes and depression were associated with lower magnesium intake (p < 0.05). A positive relationship was found between magnesium intake and HDL-cholesterol (p = 0.005). Magnesium intake was inversely correlated with triglyceride, waist circumference, body fat percent and body mass index (p < 0.005). After controlling confounding factor, HDL-cholesterol was significantly higher with increasing quartile of magnesium intake (p for trend = 0005). Waist circumference, body fat percentage, and body mass index were significantly lower with increase quartile of magnesium intake (p for trend < 0.001). The odds of depression, central obesity, high body fat percentage, and high body mass index were significantly lower with increasing quartile of magnesium intake (p for trend < 0.05). In addition, magnesium intake was related to high physical activity level and demonstrated lower serum magnesium levels. Serum magnesium was not significantly associated with metabolic parameters.

Conclusions

The majority of elderly type 2 diabetes who have low magnesium intake may compound this deficiency with metabolic abnormalities and depression. Future studies should determine the effects of increased magnesium intake or magnesium supplementation on metabolic control and depression in elderly people with type 2 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
2.
go back to reference Meneilly GS, Tessier D: Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci. 2001, 56 (1): M5-M13. 10.1093/gerona/56.1.M5.CrossRefPubMed Meneilly GS, Tessier D: Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci. 2001, 56 (1): M5-M13. 10.1093/gerona/56.1.M5.CrossRefPubMed
3.
go back to reference Huang ES, Liu JY, Moffet HH, John PM, Karter AJ: Glycemic control, complications, and death in older diabetic patients the diabetes and aging study. Diabetes Care. 2011, 34 (6): 1329-1336. 10.2337/dc10-2377.CrossRefPubMedPubMedCentral Huang ES, Liu JY, Moffet HH, John PM, Karter AJ: Glycemic control, complications, and death in older diabetic patients the diabetes and aging study. Diabetes Care. 2011, 34 (6): 1329-1336. 10.2337/dc10-2377.CrossRefPubMedPubMedCentral
4.
go back to reference de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, et al: Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009, 32 (10): 1833-1838. 10.2337/dc09-0191.CrossRefPubMedPubMedCentral de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, et al: Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009, 32 (10): 1833-1838. 10.2337/dc09-0191.CrossRefPubMedPubMedCentral
5.
go back to reference Moran A, Palmas W, Field L, Bhattarai J, Schwartz JE, Weinstock RS, et al: Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care. 2004, 27 (4): 972-977. 10.2337/diacare.27.4.972.CrossRefPubMed Moran A, Palmas W, Field L, Bhattarai J, Schwartz JE, Weinstock RS, et al: Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care. 2004, 27 (4): 972-977. 10.2337/diacare.27.4.972.CrossRefPubMed
6.
go back to reference Rizvi AA: Management of diabetes in older adults. Am J Med Sci. 2007, 333 (1): 35-47. 10.1097/00000441-200701000-00005.CrossRefPubMed Rizvi AA: Management of diabetes in older adults. Am J Med Sci. 2007, 333 (1): 35-47. 10.1097/00000441-200701000-00005.CrossRefPubMed
7.
go back to reference Rodriguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003, 26 (4): 1147-1152. 10.2337/diacare.26.4.1147.CrossRefPubMed Rodriguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003, 26 (4): 1147-1152. 10.2337/diacare.26.4.1147.CrossRefPubMed
8.
go back to reference Dong JY, Xun P, He K, Qin LQ: Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011, 34 (9): 2116-2122. 10.2337/dc11-0518.CrossRefPubMedPubMedCentral Dong JY, Xun P, He K, Qin LQ: Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011, 34 (9): 2116-2122. 10.2337/dc11-0518.CrossRefPubMedPubMedCentral
10.
go back to reference Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993, 21: 1024-1029. 10.1161/01.HYP.21.6.1024.CrossRefPubMed Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993, 21: 1024-1029. 10.1161/01.HYP.21.6.1024.CrossRefPubMed
11.
go back to reference Bohl CH, Volpe SL: Magnesium and exercise. Crit Rev Food Sci Nutr. 2002, 42 (6): 533-563. 10.1080/20024091054247.CrossRefPubMed Bohl CH, Volpe SL: Magnesium and exercise. Crit Rev Food Sci Nutr. 2002, 42 (6): 533-563. 10.1080/20024091054247.CrossRefPubMed
12.
go back to reference Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nut. 2007, 26 (2): 121-132.CrossRef Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women. J Am Coll Nut. 2007, 26 (2): 121-132.CrossRef
13.
go back to reference Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res. 2007, 38 (7): 752-756. 10.1016/j.arcmed.2007.03.008.CrossRefPubMed Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res. 2007, 38 (7): 752-756. 10.1016/j.arcmed.2007.03.008.CrossRefPubMed
14.
go back to reference McKeown NM, Jacques PF, Zhang XL, Juan W, Sahyoun NR: Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr. 2008, 47 (4): 210-216. 10.1007/s00394-008-0715-x.CrossRefPubMed McKeown NM, Jacques PF, Zhang XL, Juan W, Sahyoun NR: Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr. 2008, 47 (4): 210-216. 10.1007/s00394-008-0715-x.CrossRefPubMed
15.
go back to reference Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, et al: Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nut. 2006, 25 (3): 210-215.CrossRef Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, et al: Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nut. 2006, 25 (3): 210-215.CrossRef
16.
go back to reference Guerrero-Romero F, Rodriguez-Moran M: Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complicat. 2000, 14 (5): 272-276. 10.1016/S1056-8727(00)00127-6.CrossRefPubMed Guerrero-Romero F, Rodriguez-Moran M: Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complicat. 2000, 14 (5): 272-276. 10.1016/S1056-8727(00)00127-6.CrossRefPubMed
17.
go back to reference Corica F, Allegra A, Di Benedetto A, Giacobbe MS, Romano G, Cucinotta D, et al: Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res. 1994, 7 (1): 43-47.PubMed Corica F, Allegra A, Di Benedetto A, Giacobbe MS, Romano G, Cucinotta D, et al: Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res. 1994, 7 (1): 43-47.PubMed
18.
go back to reference Motoyama T, Sano H, Fukuzaki H: Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989, 13 (3): 227-232. 10.1161/01.HYP.13.3.227.CrossRefPubMed Motoyama T, Sano H, Fukuzaki H: Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989, 13 (3): 227-232. 10.1161/01.HYP.13.3.227.CrossRefPubMed
19.
go back to reference Finstad EW, Newhouse IJ, Lukaski HC, McAuliffe JE, Stewart CR: The effects of magnesium supplementation on exercise performance. Med Sci Sports Exerc. 2001, 33 (3): 493-498. 10.1097/00005768-200103000-00024.CrossRefPubMed Finstad EW, Newhouse IJ, Lukaski HC, McAuliffe JE, Stewart CR: The effects of magnesium supplementation on exercise performance. Med Sci Sports Exerc. 2001, 33 (3): 493-498. 10.1097/00005768-200103000-00024.CrossRefPubMed
20.
go back to reference Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res. 2008, 21 (4): 218-223.PubMed Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial. Magnes Res. 2008, 21 (4): 218-223.PubMed
21.
go back to reference Ismail Y, Ismail AA, Ismail AAA: The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med. 2010, 48 (3): 323-327.CrossRefPubMed Ismail Y, Ismail AA, Ismail AAA: The underestimated problem of using serum magnesium measurements to exclude magnesium deficiency in adults; a health warning is needed for “normal” results. Clin Chem Lab Med. 2010, 48 (3): 323-327.CrossRefPubMed
22.
go back to reference Arnaud MJ: Update on the assessment of magnesium status. Br J Nutr. 2008, 99 (Suppl 3): S24-S36.PubMed Arnaud MJ: Update on the assessment of magnesium status. Br J Nutr. 2008, 99 (Suppl 3): S24-S36.PubMed
23.
go back to reference Sales CH, Pedrosa LF, Lima JG, Lemos TM, Colli C: Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes. Clin Nutr. 2011, 30 (3): 359-364. 10.1016/j.clnu.2010.12.011.CrossRefPubMed Sales CH, Pedrosa LF, Lima JG, Lemos TM, Colli C: Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes. Clin Nutr. 2011, 30 (3): 359-364. 10.1016/j.clnu.2010.12.011.CrossRefPubMed
24.
go back to reference Thompson FE, Byers T: Dietary assessment resource manual. J Nutr. 1994, 124 (11 Suppl): 2245S-2317S.PubMed Thompson FE, Byers T: Dietary assessment resource manual. J Nutr. 1994, 124 (11 Suppl): 2245S-2317S.PubMed
25.
go back to reference Volpe SL: Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr. 2008, 48 (3): 293-300. 10.1080/10408390701326235.CrossRefPubMed Volpe SL: Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr. 2008, 48 (3): 293-300. 10.1080/10408390701326235.CrossRefPubMed
26.
go back to reference American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997, 20: 1183-1197.CrossRef American Diabetes Association: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997, 20: 1183-1197.CrossRef
27.
go back to reference American Diabetes Association: Standards of medical care in diabetes–2010. Diabetes Care. 2010, 33 (Suppl 1): 11S-61S.CrossRef American Diabetes Association: Standards of medical care in diabetes–2010. Diabetes Care. 2010, 33 (Suppl 1): 11S-61S.CrossRef
28.
go back to reference Kurukulasuriya LR, Sowers JR: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors. Cardiovasc Diabetol. 2010, 9: 45-10.1186/1475-2840-9-45.CrossRefPubMedPubMedCentral Kurukulasuriya LR, Sowers JR: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors. Cardiovasc Diabetol. 2010, 9: 45-10.1186/1475-2840-9-45.CrossRefPubMedPubMedCentral
29.
go back to reference Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004, 110: 227-239. 10.1161/01.CIR.0000133317.49796.0E.CrossRefPubMed Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, et al: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004, 110: 227-239. 10.1161/01.CIR.0000133317.49796.0E.CrossRefPubMed
30.
go back to reference Xu J, Eilat-Adar S, Loria CM, Howard BV, Fabsitz RR, Begum M, et al: Macronutrient intake and glycemic control in a population-based sample of American Indians with diabetes: the Strong Heart Study. Am J Clin Nutr. 2007, 86 (2): 480-487.PubMed Xu J, Eilat-Adar S, Loria CM, Howard BV, Fabsitz RR, Begum M, et al: Macronutrient intake and glycemic control in a population-based sample of American Indians with diabetes: the Strong Heart Study. Am J Clin Nutr. 2007, 86 (2): 480-487.PubMed
31.
go back to reference Posner BM, Smigelski C, Duggal A, Morgan IL, Cobb I, Cupples LA: Validation of two-dimensional models for estimation of portion size in nutrition research. J Am Diet Assoc. 1992, 92: 738-741.PubMed Posner BM, Smigelski C, Duggal A, Morgan IL, Cobb I, Cupples LA: Validation of two-dimensional models for estimation of portion size in nutrition research. J Am Diet Assoc. 1992, 92: 738-741.PubMed
32.
go back to reference Huang MC, Hsu CC, Wang HS, Shin SJ: Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care. 2010, 33 (2): 233-239. 10.2337/dc09-1092.CrossRefPubMed Huang MC, Hsu CC, Wang HS, Shin SJ: Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care. 2010, 33 (2): 233-239. 10.2337/dc09-1092.CrossRefPubMed
33.
go back to reference Institute of Medicine, Food and Nutrition Board: Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. 1997, National Academy Press, Washington, D.C, 71-145. Institute of Medicine, Food and Nutrition Board: Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. 1997, National Academy Press, Washington, D.C, 71-145.
34.
35.
go back to reference Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J: Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care. 2005, 28 (4): 799-805. 10.2337/diacare.28.4.799.CrossRefPubMed Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J: Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes. Diabetes Care. 2005, 28 (4): 799-805. 10.2337/diacare.28.4.799.CrossRefPubMed
36.
go back to reference Sahota PK, Knowler WC, Looker HC: Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry. 2008, 69 (5): 800-809. 10.4088/JCP.v69n0513.CrossRefPubMedPubMedCentral Sahota PK, Knowler WC, Looker HC: Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry. 2008, 69 (5): 800-809. 10.4088/JCP.v69n0513.CrossRefPubMedPubMedCentral
37.
go back to reference Hwang LC, Chen SC, Tjung JJ, Chiou HY, Chen CJ, Tsai CH: Body mass index as a predictor of mortality in older people in Taiwan. International Journal of Gerontology. 2009, 3 (1): 39-46. 10.1016/S1873-9598(09)70019-5.CrossRef Hwang LC, Chen SC, Tjung JJ, Chiou HY, Chen CJ, Tsai CH: Body mass index as a predictor of mortality in older people in Taiwan. International Journal of Gerontology. 2009, 3 (1): 39-46. 10.1016/S1873-9598(09)70019-5.CrossRef
38.
go back to reference Monami M, Lamanna C, Balzi D, Bartalucci F, Melani C, Masotti G, et al: Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal study. J Gerontol A Biol Sci Med Sci. 2008, 63 (6): 646-649. 10.1093/gerona/63.6.646.CrossRefPubMed Monami M, Lamanna C, Balzi D, Bartalucci F, Melani C, Masotti G, et al: Metabolic syndrome and cardiovascular mortality in older type 2 diabetic patients: a longitudinal study. J Gerontol A Biol Sci Med Sci. 2008, 63 (6): 646-649. 10.1093/gerona/63.6.646.CrossRefPubMed
39.
go back to reference Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107 (3): 499-511. 10.1161/01.CIR.0000052939.59093.45.CrossRefPubMed
40.
go back to reference Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al: Guidelines for the management of chronic kidney disease. CMAJ. 2008, 179 (11): 1154-1162. 10.1503/cmaj.080351.CrossRefPubMedPubMedCentral Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al: Guidelines for the management of chronic kidney disease. CMAJ. 2008, 179 (11): 1154-1162. 10.1503/cmaj.080351.CrossRefPubMedPubMedCentral
41.
go back to reference Wang JL, Weng YL, Pan WH, Kao MD: Trends and nutritional status for magnesium in Taiwan from NAHSIT 1993 to 2008. Asia Pac J Clin Nutr. 2011, 20 (2): 266-274.PubMed Wang JL, Weng YL, Pan WH, Kao MD: Trends and nutritional status for magnesium in Taiwan from NAHSIT 1993 to 2008. Asia Pac J Clin Nutr. 2011, 20 (2): 266-274.PubMed
42.
go back to reference Moshfegh AJ, Goldman JD, Ahuja JK, Rhodes DG, LaComb RP: What We Eat in America, NHANES 2005–2006: Usual nutrient intakes from food and water compared to 1997 dietary reference intakes for vitamin D, calcium, phosphorus, and magnesium (24-page report). 2009, Agricultural Research Service, US Department of Agriculture Moshfegh AJ, Goldman JD, Ahuja JK, Rhodes DG, LaComb RP: What We Eat in America, NHANES 2005–2006: Usual nutrient intakes from food and water compared to 1997 dietary reference intakes for vitamin D, calcium, phosphorus, and magnesium (24-page report). 2009, Agricultural Research Service, US Department of Agriculture
43.
go back to reference Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, Asghari G, Hosseinpour-Niazi S, Azizi F: Magnesium intake and prevalence of metabolic syndrome in adults: tehran lipid and glucose study. Public Health Nutr. 2012, 15 (4): 693-701. 10.1017/S1368980011002941.CrossRefPubMed Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F, Asghari G, Hosseinpour-Niazi S, Azizi F: Magnesium intake and prevalence of metabolic syndrome in adults: tehran lipid and glucose study. Public Health Nutr. 2012, 15 (4): 693-701. 10.1017/S1368980011002941.CrossRefPubMed
44.
go back to reference Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004, 184: 386-392. 10.1192/bjp.184.5.386.CrossRefPubMed Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004, 184: 386-392. 10.1192/bjp.184.5.386.CrossRefPubMed
45.
go back to reference Katon W, Schulberg H: Epidemiology of depression in primary care. Gen Hosp Psychiatry. 1992, 14 (4): 237-247. 10.1016/0163-8343(92)90094-Q.CrossRefPubMed Katon W, Schulberg H: Epidemiology of depression in primary care. Gen Hosp Psychiatry. 1992, 14 (4): 237-247. 10.1016/0163-8343(92)90094-Q.CrossRefPubMed
46.
go back to reference Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006, 23 (11): 1165-1173. 10.1111/j.1464-5491.2006.01943.x.CrossRefPubMed Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006, 23 (11): 1165-1173. 10.1111/j.1464-5491.2006.01943.x.CrossRefPubMed
47.
go back to reference Black SA: Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the hispanic established population for the epidemiologic study of the elderly survey. Diabetes Care. 1999, 22 (1): 56-64. 10.2337/diacare.22.1.56.CrossRefPubMed Black SA: Increased health burden associated with comorbid depression in older diabetic Mexican Americans. Results from the hispanic established population for the epidemiologic study of the elderly survey. Diabetes Care. 1999, 22 (1): 56-64. 10.2337/diacare.22.1.56.CrossRefPubMed
48.
go back to reference Pham PC, Pham PM, Pham SV, Miller JM, Pham PT: Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007, 2 (2): 366-373. 10.2215/CJN.02960906.CrossRefPubMed Pham PC, Pham PM, Pham SV, Miller JM, Pham PT: Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007, 2 (2): 366-373. 10.2215/CJN.02960906.CrossRefPubMed
49.
go back to reference Nasri H, Baradaran HR: Lipids in association with serum magnesium in diabetes mellitus patients. Bratislava Medical Journal-Bratislavske Lekarske Listy. 2008, 109 (7): 302-306. Nasri H, Baradaran HR: Lipids in association with serum magnesium in diabetes mellitus patients. Bratislava Medical Journal-Bratislavske Lekarske Listy. 2008, 109 (7): 302-306.
50.
go back to reference Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, et al: Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr. 2006, 84 (2): 419-426.PubMedPubMedCentral Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, et al: Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin Nutr. 2006, 84 (2): 419-426.PubMedPubMedCentral
51.
go back to reference Nielsen FH, Lukaski HC: Update on the relationship between magnesium and exercise. Magnesium Res. 2006, 19 (3): 180-189. Nielsen FH, Lukaski HC: Update on the relationship between magnesium and exercise. Magnesium Res. 2006, 19 (3): 180-189.
52.
go back to reference Rayssiguier Y, Guezennec CY, Durlach J: New experimental and clinical data on the relationship between magnesium and sport. Magnes Res. 1990, 3 (2): 93-102.PubMed Rayssiguier Y, Guezennec CY, Durlach J: New experimental and clinical data on the relationship between magnesium and sport. Magnes Res. 1990, 3 (2): 93-102.PubMed
53.
go back to reference McDonald R, Keen CL: Iron, zinc and magnesium nutrition and athletic performance. Sports Med. 1988, 5 (3): 171-184. 10.2165/00007256-198805030-00004.CrossRefPubMed McDonald R, Keen CL: Iron, zinc and magnesium nutrition and athletic performance. Sports Med. 1988, 5 (3): 171-184. 10.2165/00007256-198805030-00004.CrossRefPubMed
Metadata
Title
Correlation of magnesium intake with metabolic parameters, depression and physical activity in elderly type 2 diabetes patients: a cross-sectional study
Authors
Jui-Hua Huang
Yi-Fa Lu
Fu-Chou Cheng
John Ning-Yuean Lee
Leih-Ching Tsai
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2012
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-11-41

Other articles of this Issue 1/2012

Nutrition Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine